Chemours
546 hedge funds and large institutions have $6.78B invested in Chemours in 2018 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 155 increasing their positions, 181 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less capital invested
Capital invested by funds: $7.11B → $6.78B (-$325M)
14% less repeat investments, than reductions
Existing positions increased: 155 | Existing positions reduced: 181
17% less call options, than puts
Call options by funds: $61.7M | Put options by funds: $73.9M
Holders
546
Holding in Top 10
4
Calls
$61.7M
Puts
$73.9M
Top Buyers
| 1 | +$222M | |
| 2 | +$112M | |
| 3 | +$78.3M | |
| 4 |
First Eagle Investment Management
New York
|
+$56.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$48.2M |
Top Sellers
| 1 | -$113M | |
| 2 | -$96.3M | |
| 3 | -$68.2M | |
| 4 |
Goldman Sachs
New York
|
-$56.7M |
| 5 |
GC
Greenlight Capital
New York
|
-$52.5M |